Location History:
- Osaka, JP (2013)
- Tokyo, JP (2008 - 2015)
Company Filing History:
4 out of 257 
2 out of 389 
1 out of 73 
Years Active: 2008-2015
Title: Keiichi Aritomo: Innovator in Pharmaceutical Chemistry
Introduction
Keiichi Aritomo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for therapeutic applications. With a total of 5 patents to his name, Aritomo's work focuses on addressing critical health issues, including neurodegenerative diseases.
Latest Patents
Aritomo's latest patents include innovative compounds such as pyrimidone derivatives. These compounds are represented by a specific formula and are designed for the preventive and therapeutic treatment of diseases caused by abnormal activity of tau protein kinase 1, such as Alzheimer's disease. Another notable patent is for a condensed tetrahydroquinoline derivative, which aims to provide a compound with selective binding activity to glucocorticoid receptors while minimizing action on other nuclear receptors.
Career Highlights
Throughout his career, Keiichi Aritomo has worked with leading pharmaceutical companies, including Mitsubishi Tanabe Pharma Corporation and Sanofi-Aventis. His expertise in drug development has positioned him as a key figure in the industry, contributing to advancements in medical treatments.
Collaborations
Aritomo has collaborated with notable colleagues such as Kazutoshi Watanabe and Fumiaki Uehara. These partnerships have fostered innovation and have been instrumental in the successful development of his patented compounds.
Conclusion
Keiichi Aritomo's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field and offers hope for advancements in the treatment of serious health conditions.